SHMT1 and ovarian carcinoma: These studies also identified SHMT1-mediated regulation of Neu5Ac as a genetic vulnerability of ovarian cancer cells that can be targeted by approaches aimed at inhibition of Neu5Ac and by potentially inhibiting SHMT1 using specific inhibitors.